Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 317Carcinoma, Non-Small-Cell Lung 72Skin Neoplasms 65Carcinoma, Renal Cell 48Lung Neoplasms 45Breast Neoplasms 45Colorectal Neoplasms 42Carcinoma, Basal Cell 41Neoplasms 40Neoplasm Metastasis 40Squamous Cell Carcinoma of Head and Neck 36Uveal Melanoma 33Ovarian Neoplasms 33Carcinoma, Merkel Cell 32Sarcoma 31Lymphoma, T-Cell, Cutaneous 31Pancreatic Neoplasms 26Prostatic Neoplasms 24Head and Neck Neoplasms 22Stomach Neoplasms 21Thyroid Neoplasms 20Urinary Bladder Neoplasms 19Carcinoma, Hepatocellular 19Uterine Cervical Neoplasms 18Esophageal Neoplasms 18Carcinoma, Squamous Cell 18Mycosis Fungoides 16Carcinoma, Transitional Cell 16Brain Neoplasms 16Recurrence 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Plaque, Amyloid × Dermatologic × 90 days × Clear all
NCT05907954 2026-03-16

(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma

IDEAYA Biosciences

Phase 2 Active not recruiting
160 enrolled
Dermatologic

Uveal Melanoma, Plaque, Amyloid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡